| CTRI Number |
CTRI/2025/10/096250 [Registered on: 21/10/2025] Trial Registered Prospectively |
| Last Modified On: |
19/10/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Preventive Process of Care Changes |
| Study Design |
Other |
|
Public Title of Study
|
To compare the difference in the amount of blood loss during the first 24 hours after cesarean section on giving intrauterine misoprostol in one group and per rectal misoprostol in another group |
|
Scientific Title of Study
|
Intrauterine Misoprostol Versus per Rectal Misoprostol During Cesarean Section to Prevent Primary Postpartum Hemorrhage-- A Comparative analysis |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Madhumanti Banerjee |
| Designation |
Post graduate trainee |
| Affiliation |
MIDNAPORE MEDICAL COLLEGE AND HOSPITAL |
| Address |
Dept of gynaecology and obstetrics, MidnaporeMedicalCollegeandHospital, vidyasagar road ,west mindapore
Medinipur WEST BENGAL 721101 India |
| Phone |
8777018850 |
| Fax |
|
| Email |
dhu.manti@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Snehamay Chaudhuri |
| Designation |
Professor |
| Affiliation |
Midnapore medical college and hospital |
| Address |
Dept of Gynaecology and Obstetrics, Midnapore medical college and hospital, vidyasagar road , midnapore, w medinipur
Medinipur WEST BENGAL 721101 India |
| Phone |
9830538366 |
| Fax |
|
| Email |
snehamay_chaudhuri_dr@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Snehamay Chaudhuri |
| Designation |
Professor |
| Affiliation |
Midnapore medical college and hospital |
| Address |
Dept of Gynaecology and Obstetrics, Midnapore medical college and hospital, vidyasagar road , midnapore, w medinipur
Medinipur WEST BENGAL 721101 India |
| Phone |
9830538366 |
| Fax |
|
| Email |
snehamay_chaudhuri_dr@yahoo.com |
|
|
Source of Monetary or Material Support
|
| Midnapore medical college and hospital, vidyasagar road, medinipur, west Midnapore, pin 721101, state : West Bengal, country: India |
|
|
Primary Sponsor
|
| Name |
Madhumanti Banerjee |
| Address |
Dept of Gynaecology and Obstetrics, Midnapore medical College and hospital, vidyasagar road, midnapore, w medinipur |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Snehamay Chaudhuri |
Midnapore medical College and hospital |
Department of Gynaecology and Obstetrics Medinipur WEST BENGAL |
9830538366
snehamay_chaudhuri_dr@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O720||Third-stage hemorrhage, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Per rectal misoprostol |
Per rectal misoprostol 800 mcg immediate post operatively |
| Intervention |
Use of intrauterine misoprostol in preventing primary post partum hemorrhage during cesarean section |
400 mcg misoprostol will be introduced intrauterine ( 200mcg in each cornu) in first group |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Female |
| Details |
Women bearing full term singleton healthy living fetus with gestational age more than 37 weeks either confirmed from first date of last menstrual period or first trimester ultrasound scan |
|
| ExclusionCriteria |
| Details |
Women with pre operative hemoglobin less than 9gm/dl , concomittant medical disorders, more than two previous cesarean section, allergic to prostaglandin, with higher risk of post partum hemorrhage ( abnormal placentation, twin pregnancy, previous history of uterine atony or PPH, polyhydramnios,uterine fibroids ) , women in whom cesarean section lasts for more than 90 minutes |
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To study efficacy and safety of intrauterine misoprostol in preventing primary post partum hemorrhage during cesarean section as compared to per rectal misoprostol during cesarean section |
24hours |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1) to compare use of additional uterotonics following intrauterine misoprostol administration
2) to compare blood transfusion following intrauterine misoprostol administration
3) to compare hospital stay following intrauterine misoprostol administration
4) to study side effects of misoprostol |
24hours |
|
|
Target Sample Size
|
Total Sample Size="200" Sample Size from India="200"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 1 |
|
Date of First Enrollment (India)
|
01/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
A study where we compare the effectiveness of intrauterine misoprostol as compared to per rectal misoprostol during cesarean section in controlling primary post partum hemorrhage. The patients fitting the inclusion criteria will be subjected to the study after proper consent and the effectiveness will be measured with the help of a formula based primarily on the basis of difference in the hematocrit and other factors like mop soakage and suction drain content. |